As illustrated in Fig. 6i, the consistent downregulation of several stemness-associated CD markers (CD200 and CD9) and TFs (HHEX and NFATC2) was not observed in APL patients with early death (Supplementary Data 11). This evidence concerns the gene NFATC2 and acute promyelocytic leukemia.